跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 78 条关于
“Dynavax”
全部
78
临床试验
24
药物
31
机构
3
资讯
20
10个月前
Dynavax Secures Exclusive License to Vaxart's Oral COVID-19 Vaccine in $25 Million Deal
去年
Goldman Sachs Downgrades Dynavax on Competitive Pressures in Shingles and Hepatitis B Markets
去年
Dynavax Reports Strong Growth with HEPLISAV-B Revenue Up 26% in 2024, Advances Pipeline Programs
去年
Dynavax Technologies' Z-1018 Shingles Vaccine Shows Promise in Phase 1/2 Trial with Improved Safety Profile
去年
Dynavax's Z-1018 Shingles Vaccine Matches GSK's Shingrix Efficacy with Superior Tolerability in Phase I/II Trial
去年
First-In-Human Trial of TherVacB Hepatitis B Vaccine Shows Promise
3个月前
Vaxart Board Battle Intensifies as Independent Directors Urge Shareholders to Back All Six Nominees Ahead of July 16 Annual Meeting
8个月前
Sanofi Prepares Enhanced Takeover Bid for Ocular Therapeutix Following Rejected $16 Per Share Offer
去年
Sonoma Biotherapeutics Strengthens Leadership Team with Appointment of Rajesh Krishnan as Chief Technical Officer
去年
Uvax Bio's HIV-1 Vaccine Candidate Shows Promising Early Results in Phase 1 Trial
第 1 页,共 2 页
上一页
下一页